University of Kansas Medical Center
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1906-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- https://www.kumc.edu
fMRI Study Examining Effects of D-cycloserine in Specific Phobia
- First Posted Date
- 2008-01-11
- Last Posted Date
- 2017-06-05
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 54
- Registration Number
- NCT00591825
- Locations
- 🇺🇸
University of Kansas Medical Center, Hoglund Brain Imaging Center, Kansas City, Kansas, United States
Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer
Phase 2
Terminated
- Conditions
- Head and Neck CancerCarcinoma, Squamous
- Interventions
- First Posted Date
- 2008-01-11
- Last Posted Date
- 2017-06-14
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 16
- Registration Number
- NCT00591149
- Locations
- 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States
Physical Inactivity and Insulin Resistance in Skeletal Muscle.
Not Applicable
Withdrawn
- Conditions
- Metabolic Syndrome XInsulin ResistanceHypertensionHypercholesterolemiaObesity
- Interventions
- Behavioral: Exercise
- First Posted Date
- 2007-09-27
- Last Posted Date
- 2021-05-04
- Lead Sponsor
- University of Kansas Medical Center
- Registration Number
- NCT00536211
- Locations
- 🇺🇸
Harry S. Truman Memorial Veterans' Hospital, Columbia, Missouri, United States
Erlotinib Plus Chemotherapy for Treatment of Triple Negative Breast Cancer
- First Posted Date
- 2007-06-26
- Last Posted Date
- 2017-01-19
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 32
- Registration Number
- NCT00491816
- Locations
- 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States
A Trial of Pyridoxamine to Lower Urine Oxalate in Subjects With Stone Disease or Hyperoxaluria
- First Posted Date
- 2007-06-22
- Last Posted Date
- 2017-01-05
- Lead Sponsor
- University of Kansas Medical Center
- Registration Number
- NCT00490113
Azacitidine and Cisplatin for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
- First Posted Date
- 2007-03-05
- Last Posted Date
- 2017-02-27
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 1
- Registration Number
- NCT00443261
- Locations
- 🇺🇸
Kansas City VA Medical Center, Kansas City, Missouri, United States
Pharmacogenomic Study in Patients of Lung, Colorectal and Head/Neck Cancers Receiving Chemotherapy
Completed
- Conditions
- Head and Neck CancerColorectal CancerLung Cancer
- First Posted Date
- 2007-03-02
- Last Posted Date
- 2016-11-28
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 70
- Registration Number
- NCT00442520
- Locations
- 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States
Disease Management for Smoking Cessation
Phase 3
Completed
- Conditions
- Smoking Cessation
- Interventions
- Behavioral: Comparison groupBehavioral: High intensity disease managementBehavioral: Low intensity disease management
- First Posted Date
- 2007-02-26
- Last Posted Date
- 2017-06-07
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 750
- Registration Number
- NCT00440115
- Locations
- 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States
Brain Aging Project--Kansas University
Completed
- Conditions
- Alzheimer's Disease
- First Posted Date
- 2005-12-20
- Last Posted Date
- 2017-04-06
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 172
- Registration Number
- NCT00267124
- Locations
- 🇺🇸
University of Kansas Medical Center, Kansas City, Kansas, United States
A Study Evaluating Efficacy, Toxicity, Harvest Yield and Quality of Life
Phase 2
Completed
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2017-07-02
- Lead Sponsor
- University of Kansas Medical Center
- Target Recruit Count
- 25
- Registration Number
- NCT00222105
© Copyright 2025. All Rights Reserved by MedPath